Join us on the Divis Labs Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock.

Discover the Divis Labs Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a top-performing stock. Keep track of Divis Labs's latest details, including: Last ...

Divi’s Laboratories has received a draft tax assessment order proposing ₹570.51 crore in additions to FY23 income due to transfer pricing and corporate tax adjustments, with potential tax liability ...

Divi’s Labs could emerge as a key beneficiary of the global GLP-1 drug boom, with new peptide manufacturing contracts and ...

Nuvama has reiterated its 'Buy' rating for Divi's Laboratories, emphasising the company's strategic position in manufacturing ingredients for Orforglipron, a promising oral GLP-1 treatment developed ...